Gå ubegrenset med Magzter GOLD

Gå ubegrenset med Magzter GOLD

Få ubegrenset tilgang til over 9000 magasiner, aviser og premiumhistorier for bare

$149.99
 
$74.99/År
The Perfect Holiday Gift Gift Now

CLINICAL APPROACHES TO MALNUTRITION IN CHRONIC DISEASE PATIENTS

Healthcare Radius

|

May 2025

Nutrition care process to be a clinical, structured, and personalized approach — driven by interprofessional collaboration and technological integration— can transform outcomes for chronic metabolic disease patients.

- Bhakti Samant

CLINICAL APPROACHES TO MALNUTRITION IN CHRONIC DISEASE PATIENTS

Malnutrition refers to deficiencies or excesses in nutrient intake, imbalance of essential nutrients or impaired nutrient utilization. The double burden of malnutrition consists of both under-nutrition and overweight and obesity, as well as diet-related non-communicable diseases. It is a silent epidemic frequently overlooked in patients who have chronic diseases. Whether the patient has cancer, chronic kidney disease (CKD), chronic obstructive pulmonary disease (COPD), liver cirrhosis, or heart failure, disease-related malnutrition [DRM] has a significant impact on the clinical outcome. For the healthcare areas, it's important not to sideline malnutrition as it adds value in patient care.

Understanding DRM plays a pivotal role. It is a multifactorial condition resulting from the interplay between inadequate food intake, catabolic stress, inflammation and altered metabolism. The systemic Inflammation during a chronic disease state triggers hyper-metabolism, leading to proteolysis and lipolysis, resulting in loss of muscle and a decline in functional capacity.

imagePatients with chronic metabolic diseases may be presented with:

• Reduced dietary intake due to the presence of Anorexia, gastrointestinal symptoms or drug-nutrient interaction.

• Increased nutrient requirement due to reduced intake as increased metabolic demands and impaired metabolism causing malabsorption.

• Muscle loss leading to diseases such as Sarcopenia and cachexia.

There are multiple clinical implications of malnutrition in chronic disease as it's associated with:

• Higher infection rates

• Delayed recovery or impaired wound healing

• Increased length of hospital stay

• Poor tolerance to the treatment

• Increased mortality and morbidity

FLERE HISTORIER FRA Healthcare Radius

Healthcare Radius

Healthcare Radius

VENUS REMEDIES GETS DRUG APPROVALS IN VIETNAM

Venus Remedies, a fixed-dosage injectable manufacturer, has secured new marketing authorisations for Methotrexate, Cefuroxime, and Irinotecan in Vietnam.

time to read

1 mins

December 2025

Healthcare Radius

Healthcare Radius

A HEALTHIER INDIA IN THE MAKING: LEADERS DECODE THE ROAD FROM 2025 TO 2026

The collective goal is clear and unanimous: to transition from a system that primarily treats sickness to one that actively promotes lifelong health and well-being.

time to read

12 mins

December 2025

Healthcare Radius

Healthcare Radius

FROM GENES TO CARE: ADVANCING CLINICAL UNDERSTANDING OF HYPOPHOSPHATASIA

From genes to care, the story of hypophosphatasia reminds us that progress in medicine isn't only about scientific discovery, it's about turning knowledge into healing.

time to read

6 mins

December 2025

Healthcare Radius

ALEMBIC PHARMA GETS USFDA NOD FOR DILTIAZEM TABLETS IN THE US

Alembic Pharmaceuticals (Alembic) Aamour announced that it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Diltiazem Hydrochloride Tablets USP, 30 mg, 60 mg, 90 mg, and 120 mg.

time to read

1 min

December 2025

Healthcare Radius

Healthcare Radius

ZYDUS GETS USFDA APPROVAL FOR PROSTATE CANCER INJECTABLE

Zydus Lifesciences has received final approval from the United States Food and Drug Administration (USFDA) for Leuprolide Acetate injection, 14 mg/2.8 mL (1 mg/0.2 mL) multiple-dose vial (USRLD: Lupron Injection®, 1 mg/0.2 mL).

time to read

1 min

December 2025

Healthcare Radius

Healthcare Radius

SUPERHEALTH LAUNCHES HONEST SECOND OPINION FOR PATIENTS

Superhealth, a zero-wait, commission Superhealth, zerohospital network, announced the launch of \"Honest Second Opinion,\" a service that helps patients make informed decisions about their treatment plans and surgical recommendations.

time to read

1 min

December 2025

Healthcare Radius

Healthcare Radius

KOTAK ALTS INVESTS RS 400MN IN MEDIVERSAL

Kotak Alternate Asset Managers (Kotak Alts), through its Kotak Life Science Fund I, which invests in early to growth-stage life sciences and healthcare businesses, has made an investment of Rs 400 million in Mediversal Healthcare.

time to read

1 min

December 2025

Healthcare Radius

Healthcare Radius

INVIGA HEALTHCARE FUND ACQUIRES 21% STAKE IN FORUS HEALTH

Inviga Healthcare Fund (IHF), the private equity platform founded by Dr B. S. Ajaikumar of HCG, has acquired a 21 per cent stake in Forus Health, an ophthalmic diagnostics company whose devices have screened over 22 million patients across 75+ countries.

time to read

1 min

December 2025

Healthcare Radius

Healthcare Radius

OPTIMISING MATERNITY OPS: REDUCING C-SECTION BURDEN THROUGH EVIDENCE-BASED PROTOCOLS

By building systems that support safety, documentation, and respectful care, institutions can improve outcomes, lower litigation risks, and strengthen quality scores, achieving what healthcare should truly represent: Care Through Trust.”

time to read

7 mins

December 2025

Healthcare Radius

Healthcare Radius

MENTAL HEALTH CARE GOES DIGITAL WITH NEW THERAPY PLATFORM

Following the global observance and continuing the commitment to mental well-being, renowned clinical psychologist Kanika Jindal announced the launch of Harmony Therapy World, a holistic digital platform designed to bring emotional healing and psychological support to people everywhere, privately, compassionately, and without barriers.

time to read

1 min

December 2025

Listen

Translate

Share

-
+

Change font size

Holiday offer front
Holiday offer back